Skip to main content
. 2017 Apr 18;8(33):54518–54527. doi: 10.18632/oncotarget.17171

Table 4. Associations between CXCL12 SNPs and CAD.

SNP Model Genotype control case Crude analysis adjusted by age and gender
OR (95% CI) p-value OR (95% CI) p-value
rs266089 Codominant G/G 487 (71.2%) 391 (65.5%) 1 0.086 1 0.18
G/A 175 (25.6%) 185 (31%) 1.32 (1.03-1.68) 1.31(0.97-1.75)
A/A 22 (3.2%) 21 (3.5%) 1.19 (0.64-2.19) 0.91(0.43-1.94)
Dominant G/G 487 (71.2%) 391 (65.5%) 1 0.028 1 0.11
G/A-A/A 197 (28.8%) 206 (34.5%) 1.30 (1.03-1.65) 1.26(0.95-1.67)
Recessive G/G-G/A 662 (96.8%) 576 (96.5%) 1 0.77 1 0.65
A/A 22 (3.2%) 21 (3.5%) 1.10 (0.60-2.02) 0.84(0.40-1.78)
Log-additive --- --- --- 1.23 (1.00-1.50) 0.048 1.17(0.91-1.49) 0.22
rs10793538 Codominant A/A 594 (87.2%) 544 (91.1%) 1 0.06 1 0.61
T/A 81 (11.9%) 51 (8.5%) 0.69 (0.48-0.99) 0.91(0.58-1.41)
T/T 6 (0.9%) 2 (0.3%) 0.36 (0.07-1.81) 0.40(0.05-3.21)
Dominant A/A 594 (87.2%) 544 (91.1%) 1 0.025 1 0.54
T/A-T/T 87 (12.8%) 53 (8.9%) 0.67 (0.46-0.95) 0.87(0.57-1.35)
Recessive A/A-T/A 675 (99.1%) 595 (99.7%) 1 0.2 1 0.37
T/T 6 (0.9%) 2 (0.3%) 0.38 (0.08-1.88) 0.40(0.05-3.25)
Log-additive --- --- --- 0.67 (0.48-0.94) 0.018 0.86(0.57-1.28) 0.45

p <0.05, statistical significance.